OR WAIT null SECS
February 01, 2023
Location serves as the US flagship for company’s global pharma development network.
January 30, 2023
Project—which is expected to double plant’s distribution capacity—will be completed by end of Q3.
January 27, 2023
Complex to develop cGMP-compliant, commercial-scale plasmid DNA.
January 26, 2023
Companies to release variety of options for this sector.
January 25, 2023
Expansion expected to help tackle health issues at a faster rate, company says
January 24, 2023
Transaction expected to close early this year
January 23, 2023
Creates Cellular Origins in order to simplify the late-stage development process
January 20, 2023
North Carolina facility to manufacture Pfizer’s pipeline products
January 19, 2023
Nottingham location expected to be fully operational by the end of 2023
January 18, 2023
Platform is expected to streamline batch turnaround times